Crispr Therapeutics: FDA Filing on Sickle Cell Gene Therapy Is Almost Done

An approval filing for a breakthrough treatment of sickle cell disease should be done by March, Crispr Therapeutics said, highlighting the company’s lead in a competitive area of medical research and ...

An Alzheimer’s Drug’s Big Surprise: What It Means

Until this past week, there seemed to be no answers to the Alzheimer’s puzzle. The leading theory of the disease, that it was caused by a buildup of beta amyloid plaque in the brain, had been disprove...

Buy Eli Lilly Stock. Its Obesity Drug Mounjaro Will Be a Hit, Analyst Says.

Text size Eli Lily said in August that initial demand for Mounjaro was strong. Daniel Acker/Bloomberg Eli Lilly’s novel treatment for diabetes and obesity could become one of history’s bestselling dru...

Axsome Stock Is Flying as Fast-Acting Depression Drug Wins FDA Approval

Text size The decision on the drug came a bit less than a year after the FDA’s self-imposed deadline on making a call had passed. Dreamstime The Food and Drug Administration issued a long-awaite...

FAA Boeing 787 approval could spell good news for these stocks

The companies that supply components for the 787 Dreamliner could benefit from the FAA’s reported approval of a Boeing Co. process for validating fixes to each plane before they are shipped to custome...

Boeing Clears Hurdle for Resuming 787 Dreamliner Deliveries

U.S. air-safety regulators signed off on a Boeing plan aimed at addressing problems with the 787 Dreamliner, a major step before the company restarts deliveries of the aircraft, according to people fa...

Axsome Therapeutics Stock Soars on Proposed FDA Labeling for Depression Drug

Text size Axsome is reviewing the proposed labeling from the FDA. Dreamstime Shares of Axsome Therapeutics were soaring Monday after the biopharmaceutical company announced some good news in an attemp...